XML 46 R17.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2023
Income Taxes [Abstract] |
Income Taxes | 9. Income Taxes Loss before income taxes is comprised of (in thousands):
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
United States |  | $ | (334,707 | ) |  | $ | (258,493 | ) |  | $ | (29,966 | )
Foreign |  |  | 742 |  |  |  | 508 |  |  |  | 818 |
Loss before income taxes |  | $ | (333,965 | ) |  | $ | (257,985 | ) |  | $ | (29,148 | )
Our income tax expense (benefit) was as follows (in thousands):
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Current: |  |  |  |  |  |  |  |  |
Federal |  | $ | 35,861 |  |  | $ | 10,522 |  |  | $ | (200 | )
State |  |  | (3,687 | ) |  |  | 1,129 |  |  |  | (690 | )
Foreign |  |  | 147 |  |  |  | 86 |  |  |  | 339 |
Total current income tax expense (benefit) |  |  | 32,321 |  |  |  | 11,737 |  |  |  | (551 | )
Deferred: |  |  |  |  |  |  |  |  |  |  |  |
Federal |  |  | — |  |  |  | — |  |  |  | — |
State |  |  | — |  |  |  | — |  |  |  | — |
Total deferred income tax benefit |  |  | — |  |  |  | — |  |  |  | — |
Total income tax expense (benefit) |  | $ | 32,321 |  |  | $ | 11,737 |  |  | $ | (551 | )
Our expense (benefit) for income taxes differs from the amount computed by applying the U.S. federal statutory rate to loss before income taxes. The sources and tax effects of the differences are as follows (in thousands):
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Pre-tax loss |  | $ | (333,965 | ) |  |  |  |  | $ | (257,985 | ) |  |  |  |  | $ | (29,148 | ) |  |  |
Statutory rate |  |  | (70,133 | ) |  |  | 21.0 | % |  |  | (54,177 | ) |  |  | 21.0 | % |  |  | (6,121 | ) |  |  | 21.0 | %
State income tax net of federal benefit |  |  | (22,597 | ) |  |  | 6.8 | % |  |  | (13,622 | ) |  |  | 5.3 | % |  |  | 4,278 |  |  |  | (14.7 | )%
Foreign |  |  | (22 | ) |  |  | 0.0 | % |  |  | (49 | ) |  |  | 0.0 | % |  |  | 143 |  |  |  | (0.5 | )%
Net change in valuation allowance |  |  | 175,388 |  |  |  | (52.5 | )% |  |  | 104,951 |  |  |  | (40.7 | )% |  |  | 2,885 |  |  |  | (9.9 | )%
Loss on debt transactions |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 262 |  |  |  | (0.9 | )%
Tax credits |  |  | (67,131 | ) |  |  | 20.1 | % |  |  | (39,729 | ) |  |  | 15.4 | % |  |  | (23,198 | ) |  |  | 79.6 | %
Deferred tax true-up |  |  | 4 |  |  |  | 0.0 | % |  |  | (20 | ) |  |  | 0.0 | % |  |  | (24 | ) |  |  | 0.1 | %
Tax rate change |  |  | 1,023 |  |  |  | (0.3 | )% |  |  | (3,091 | ) |  |  | 1.2 | % |  |  | 12,838 |  |  |  | (44.0 | )%
Non-deductible compensation |  |  | 3,814 |  |  |  | (1.1 | )% |  |  | 3,023 |  |  |  | (1.2 | )% |  |  | 5,085 |  |  |  | (17.4 | )%
Other non-deductible items |  |  | 327 |  |  |  | (0.1 | )% |  |  | 57 |  |  |  | 0.0 | % |  |  | 84 |  |  |  | (0.3 | )%
Foreign-derived intangible income benefit |  |  | (7,493 | ) |  |  | 2.2 | % |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  |  | 19,546 |  |  |  | (5.9 | )% |  |  | 14,030 |  |  |  | (5.4 | )% |  |  | 4,720 |  |  |  | (16.2 | )%
Other |  |  | (405 | ) |  |  | 0.1 | % |  |  | 364 |  |  |  | (0.1 | )% |  |  | (1,503 | ) |  |  | 5.1 | %
Effective rate |  | $ | 32,321 |  |  |  | (9.7 | )% |  | $ | 11,737 |  |  |  | (4.5 | )% |  | $ | (551 | ) |  |  | 1.9 | %
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities as of December 31, 2023 and 2022 are as follows (in thousands):
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |
Deferred Tax Assets: |  |  |  |  |  |
Net operating loss carryovers |  | $ | 77,964 |  |  | $ | 87,802 |
Tax credits |  |  | 239,962 |  |  |  | 277,436 |
Deferred revenue |  |  | 71,683 |  |  |  | 85,700 |
Stock-based compensation |  |  | 77,468 |  |  |  | 86,983 |
Intangible and capital assets |  |  | 104,380 |  |  |  | 104,649 |
Convertible debt |  |  | 16,849 |  |  |  | 34,384 |
Capitalized research and development expenses |  |  | 238,738 |  |  |  | 119,635 |
Long-term lease liabilities |  |  | 43,718 |  |  |  | 45,612 |
Sale of future royalties |  |  | 144,608 |  |  |  | — |
Other |  |  | 10,343 |  |  |  | 15,813 |
Total deferred tax assets |  | $ | 1,025,713 |  |  | $ | 858,014 |
Deferred Tax Liabilities: |  |  |  |  |  |  |  |
Fixed assets |  |  | (4,166 | ) |  |  | (4,475 | )
Right-of-use assets |  |  | (42,007 | ) |  |  | (44,504 | )
Other |  |  | (1,910 | ) |  |  | (313 | )
Net deferred tax asset |  | $ | 977,630 |  |  | $ | 808,722 |
Valuation allowance |  |  | (977,630 | ) |  |  | (808,722 | )
Total net deferred tax assets and liabilities |  | $ | — |  |  | $ | — |
We evaluate our deferred tax assets regularly to determine whether adjustments to the valuation allowance are appropriate due to changes in facts or circumstances, such as changes in expected future pre-tax earnings, tax law, interactions with taxing authorities and developments in case law. In making this evaluation, we rely on our recent history of pre-tax earnings. Our material assumptions are our forecasts of future pre-tax earnings and the nature and timing of future deductions and income represented by the deferred tax assets and liabilities, all of which involve the exercise of significant judgment. Although we believe our estimates are reasonable, we are required to use significant judgment in determining the appropriate amount of valuation allowance recorded against our deferred tax assets. Our valuation allowance increased by $169 million from December 31, 2022 to December 31, 2023. The increase was primarily related to increases in our deferred tax assets for capitalized research and development expenses and sale of future royalties. At December 31, 2023, we had federal and state, primarily California, tax net operating loss carryforwards of $242.8 million and $398.8 million, respectively. Our federal tax loss carryforwards are available indefinitely. Our California tax loss carryforwards will begin to expire in 2032. At December 31, 2023, we also had federal and California research and development tax credit carryforwards of $169.7 million and $124.4 million, respectively. Our federal research and development tax credit carryforwards will begin to expire in 2038. Our California research and development tax credit carryforwards are available indefinitely. Our 2023 current tax expense includes a benefit of approximately $3.2 million related to utilization of state tax loss carryforwards, primarily California. Utilization of the net operating loss and tax credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. We analyze filing positions in all U.S. federal, state and foreign jurisdictions where we file income tax returns, and all open tax years in these jurisdictions to determine if we have any uncertain tax positions on any of our income tax returns. We recognize the impact of an uncertain tax position on an income tax return at the largest amount that the relevant taxing authority is more-likely-than not to sustain upon audit. We do not recognize uncertain income tax positions if they have less than 50 percent likelihood of the applicable tax authority sustaining our position. The following table summarizes our gross unrecognized tax benefits (in thousands):
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Beginning balance of unrecognized tax benefits |  | $ | 56,567 |  |  | $ | 55,085 |  |  | $ | 54,163 |
Decrease for lapse of statute of limitations |  |  | (14,993 | ) |  |  | — |  |  |  | — |
Decrease for prior period tax positions |  |  | (737 | ) |  |  | (267 | ) |  |  | (695 | )
Increase for prior period tax positions |  |  | 429 |  |  |  | 259 |  |  |  | 263 |
Increase for current period tax positions |  |  | 2,032 |  |  |  | 1,490 |  |  |  | 1,354 |
Ending balance of unrecognized tax benefits |  | $ | 43,298 |  |  | $ | 56,567 |  |  | $ | 55,085 |
Included in the balance of unrecognized tax benefits at December 31, 2023, 2022 and 2021 was $0.3 million, $6.2 million and $6.2 million respectively, that if we recognized, could impact our effective tax rate, subject to our remaining valuation allowance. We estimate that it is reasonably possible that the balance of our gross unrecognized tax benefits may decrease by approximately $7.6 million within the next 12 months due to the lapse of statute of limitations on underlying tax positions primarily related to amortization of certain capitalized state research and development expenditures. We recognize interest and/or penalties related to income tax matters in income tax expense. During the years ended December 31, 2023, 2022 and 2021, we recognized $0.1 million, $0.8 million and $0.5 million, respectively, of accrued interest and penalties related to gross unrecognized tax benefits. We are subject to taxation in the U.S. and various state and foreign jurisdictions. U.S. tax years 2020 through 2022 remain open to examination and tax years 2019 through 2022 remain open to examination by major state taxing jurisdictions, primarily California, although net operating loss and credit carryforwards generated prior to these periods may still be adjusted upon examination by the Internal Revenue Service or state tax authorities if they have been used in an open period or are used in a future period.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//740/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration